SL
Sean Laaman Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
76.9%
Neutral
23.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Downgraded
| $204 |
15%
upside
| 3 | +18% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Equal-Weight
Downgraded
| $48 |
9%
upside
| 3 | +2% |
0
%
| 8 Jan ‘26 10 days ago |
|
|
|
Overweight
Initiated
| $96 |
26%
upside
| 1 | +3.9% |
0
%
| 6 Jan ‘26 12 days ago |
|
|
|
Equal-Weight
Maintained
| $12 |
26%
upside
| 1 | – |
–
| 18 Dec ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $20 |
75%
upside
| 1 | -1.1% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Overweight
Initiated
| $34 |
100%
upside
| 1 | +28% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $115 |
62%
upside
| 1 | +13% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $304 |
18%
upside
| 1 | -5.1% |
0
%
| 21 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $383 |
13%
upside
| 1 | +16% |
0
%
| 20 Oct ‘25 3 months ago |
|